Company intelligence / Profile preview

Elan

Dublin, Irelandelanfinancialservices.com ↗

Ownership: Private
Employees: ~2000
Development stage: Commercial

Overview

Elan was a leading Irish pharmaceutical company with a focus on neurology and autoimmune diseases. Its most notable commercial product was natalizumab ("Tysabri"), co-developed with Biogen Idec for multiple sclerosis and Crohn’s disease. The company also advanced monoclonal antibody therapies for Alzheimer’s (notably bapineuzumab in partnership with Wyeth), but these did not achieve regulatory approval. After financial turmoil in the early-to-mid–2000s and divestment of key assets like Tysabri rights to Biogen Idec in early–2013, Elan was acquired by Perrigo later that year.

Therapeutic areas: OncologyImmunologyGastroenterologyNeurologyInfectious Diseases
Modalities: Small moleculeMonoclonal antibodyBiologic (for drug delivery technologies and formulations)
Industry: Biotech

Partnerships

Biogen Idec (Tysabri/natalizumab)Wyeth/Pfizer (bapineuzumab)Organon/Mercknumerous licensing/joint ventures in the '90s/'00s

Beyond the preview

Go deeper on Elan.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elan.

Explore the full profile